At my worst, I smoked 20 cigarettes a day. So my reaction on hearing the news of a daily pill, to be handed out free on the ...

The new paper, published Wednesday in The New England Journal of Medicine, showed that the compound in the diabetes drug ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

Jim Gaffigan has always used his weight and love for eating as a punchline in his comedy, even going so far to title his 2013 ...

Regulatory watchdog South African Health Products Regulatory Authority said these types of products pose a health risk to the public.

GLP-1 agonists – of which Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide) are the most ...

Fans who watched Jim Gaffigan play Tim Walz on Saturday Night Live throughout election season might have noticed something ...

Jim Gaffigan is getting candid about his weight loss journey - and how deciding to use the drug Mounjaro has helped. "I was ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

A special event is aimed at answering questions and giving local residents the best information about those medications.

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...